Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Stryker Corp (SYK) Insider Trading Activity
Healthcare • Medical Devices • 52,000 employees
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Total Value
-$203,451,180.44
Total Shares
-431,765
Average Trade Value
-$3,989,238.83
Most Active Insider
Stryker Ronda E
Total Activity: $145,952,139
Largest Single Transaction
$36,745,905
by Lobo Kevin on Nov 7, 2024
30-Day Activity
1 Transaction
Volume: 30 shares
Value: $11,181
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Vp, Chief Accounting Officer
Officer
|
Dec 17, 2024 | 30 | $11,181 | 5,040 (-0.6%) | Payment of Exercise Price | |
Vp, Chief Financial Officer
Officer
|
Nov 18, 2024 | 2,979 | $1,162,048 | 4,373 (-68.1%) | Payment of Exercise Price | |
Vp, Chief Financial Officer
Officer
|
Nov 18, 2024 | 4,500 | $551,295 | 7,352 (+61.2%) | Exercise/Conversion | |
Group President
Officer
|
Nov 15, 2024 | 514 | $201,056 | 50,611 (-1.0%) | Sale | |
Chair and CEO
Director, Officer
|
Nov 7, 2024 | 156,890 | $14,600,183 | 256,917 (+61.1%) | Exercise/Conversion | |
Chair and CEO
Director, Officer
|
Nov 7, 2024 | 15,866 | $5,866,454 | 100,027 (-15.9%) | Sale | |
Chair and CEO
Director, Officer
|
Nov 7, 2024 | 18,269 | $6,722,079 | 139,071 (-13.1%) | Sale | |
Chair and CEO
Director, Officer
|
Nov 7, 2024 | 99,577 | $36,745,905 | 157,340 (-63.3%) | Payment of Exercise Price | |
Chair and CEO
Director, Officer
|
Nov 7, 2024 | 23,178 | $8,542,947 | 115,893 (-20.0%) | Sale | |
Director, 10% Owner
|
Nov 5, 2024 | 9,254 | $3,365,217 | 3,307,354 (-0.3%) | Sale | |
Director, 10% Owner
|
Nov 5, 2024 | 10,774 | $3,938,220 | 3,267,748 (-0.3%) | Sale | |
Vp, Chief Corp Affairs Officer
Officer
|
Nov 5, 2024 | 3,189 | $1,170,044 | 30,749 (-10.4%) | Payment of Exercise Price | |
Director, 10% Owner
|
Nov 5, 2024 | 49,028 | $18,022,693 | 3,186,635 (-1.5%) | Sale | |
Director, 10% Owner
|
Nov 5, 2024 | 59,652 | $21,981,762 | 3,126,983 (-1.9%) | Sale | |
Director, 10% Owner
|
Nov 5, 2024 | 28,832 | $10,511,571 | 3,278,522 (-0.9%) | Sale | |
Director, 10% Owner
|
Nov 5, 2024 | 39,211 | $14,483,367 | 3,087,772 (-1.3%) | Sale | |
Vp, Chief Corp Affairs Officer
Officer
|
Nov 5, 2024 | 4,980 | $481,267 | 33,938 (+14.7%) | Exercise/Conversion | |
Director, 10% Owner
|
Nov 5, 2024 | 1,164 | $430,761 | 3,086,608 (-0.0%) | Sale | |
Director, 10% Owner
|
Nov 5, 2024 | 32,085 | $11,761,398 | 3,235,663 (-1.0%) | Sale | |
Group President
Officer
|
Oct 1, 2024 | 552 | $199,416 | 51,254 (-1.1%) | Payment of Exercise Price | |
Group President
Officer
|
Oct 1, 2024 | 641 | $231,568 | 55,611 (-1.2%) | Payment of Exercise Price | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 635 | $231,500 | 14,686 (-4.3%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 1,336 | $483,945 | 15,795 (-8.5%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 680 | $250,955 | 12,128 (-5.6%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 422 | $157,222 | 10,042 (-4.2%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 931 | $341,822 | 13,268 (-7.0%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 460 | $169,269 | 12,808 (-3.6%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 134 | $49,665 | 11,994 (-1.1%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 1,530 | $568,518 | 10,464 (-14.6%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 258 | $93,191 | 17,131 (-1.5%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 487 | $177,904 | 14,199 (-3.4%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 17, 2024 | 474 | $172,194 | 15,321 (-3.1%) | Sale | |
Vp, Chief Hr Officer
Officer
|
Sep 16, 2024 | 7,347 | $900,081 | 17,389 (+42.3%) | Exercise/Conversion | |
Vp, Chief Hr Officer
Officer
|
Sep 13, 2024 | 2,121 | $784,770 | 10,042 (-21.1%) | Sale | |
Vp, Chief Accounting Officer
Officer
|
Aug 28, 2024 | 1,255 | $0 | 5,070 (+24.8%) | Grant | |
Group President
Officer
|
Aug 27, 2024 | 600 | $213,000 | 9,069 (-6.6%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 3,079 | $978,168 | 3,501,408 (-0.1%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 58,631 | $19,024,587 | 3,339,538 (-1.8%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 2,121 | $672,251 | 3,504,487 (-0.1%) | Sale | |
Vp, Chief Legal Officer
Officer
|
Aug 6, 2024 | 633 | $0 | 9,182 (+6.9%) | Grant | |
Director, 10% Owner
|
Aug 6, 2024 | 3,594 | $1,148,499 | 3,497,814 (-0.1%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 17,927 | $5,834,342 | 3,321,611 (-0.5%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 41,519 | $13,432,227 | 3,398,169 (-1.2%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 3,944 | $1,267,720 | 3,487,786 (-0.1%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 6,084 | $1,949,739 | 3,491,730 (-0.2%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 48,098 | $15,518,339 | 3,439,688 (-1.4%) | Sale | |
Director, 10% Owner
|
Aug 6, 2024 | 5,003 | $1,631,278 | 3,316,608 (-0.2%) | Sale | |
Vp, Chief Financial Officer
Officer
|
Aug 2, 2024 | 20,000 | $6,660,000 | 2,852 (-701.3%) | Sale | |
Vp, Chief Legal Officer
Officer
|
Aug 1, 2024 | 347 | $113,625 | 8,549 (-4.1%) | Payment of Exercise Price | |
Vp, Chief Financial Officer
Officer
|
Jul 2, 2024 | 25,000 | $3,062,750 | 40,012 (+62.5%) | Exercise/Conversion | |
Vp, Chief Financial Officer
Officer
|
Jul 2, 2024 | 17,160 | $5,774,340 | 22,852 (-75.1%) | Payment of Exercise Price |